Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value.

Core Evid · 2007 · PMC3012430 · PMID 21221178

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results showed a trend favoring insulin glargine both in terms of glycemic control and reduced hypoglycemia.

also in 53,322 other papers

a nonsignificant trendno p-value reported

The frequency of symptomatic hypoglycemia was similar between the two groups despite a nonsignificant trend to fewer episodes of severe hypoglycemia and severe nocturnal hypoglycemia in those treated with insulin glargine.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.